Illumina Investors Claim Goldman Bias In Suit Over Roche Bid
By Ian Thoms · February 15, 2012, 4:04 PM EST
A group of Illumina Inc. shareholders launched a putative class action Tuesday accusing the gene sequencing company and its board of directors of deciding to reject a takeover bid by drugmaker...
To view the full article, register now.
Try a seven day FREE Trial
Already a subscriber? Click here to login